Pfizer: New York Judge Tosses Celebrex Testimony

NEW YORK - For the second time in three months a judge has ruled that there is insufficient data to show that Celebrex can cause heart attacks and stroke at its most commonly prescribed dosage. In Re: New York Bextra/Celebrex Product Liability Litigation, No. 109535/05 (N.Y. Sup. Ct., New York Cty.).

Pfizer Inc. said Jan. 9 that New York County Supreme Court Justice Shirley W. Kornreich granted a motion to exclude the plaintiffs' expert testimony that patients taking 200 mg of Celebrex per day face an increased risk of cardiovascular injury.

Pfizer said that Justice Kornreich's decision, in conjunction with …